Back to search

Article

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on hemodialysis

2021-05-29

Abstract excerpt

<h4>Background</h4> Patients with chronic renal insufficiency on intermittent hemodialysis face an increased risk of COVID-19 induced mortality and impaired vaccine responses. To date, only few studies addressed SARS-CoV-2 vaccine elicited immunity in this immunocompromised population. <h4>Methods</h4> We assessed immunogenicity of the mRNA vaccine BNT162b2 in at risk dialysis patients and characterized systemic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7f404d9c-a83e-5381-a16b-7f67d795ece1
DOI
10.1101/2021.05.26.21257860
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on hemodialysisDOI 10.1101/2021.05.26.21257860
Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort studySemantic proximity
Justification, safety, and efficacy of a third dose of mRNA vaccine in maintenance hemodialysis patients: a prospective observational studySemantic proximity
Humoral Response to BNT162b2 mRNA Covid19 Vaccine in Peritoneal and Hemodialysis Patients: a Comparative StudySemantic proximity
Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patientsSemantic proximity
Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patientsSemantic proximity
Diminishing immune responses against variants of concern in dialysis patients four months after SARS-CoV-2 mRNA vaccinationSemantic proximity
A Malaysian Study on COVID-19 (SARS-CoV-2) Vaccination Immune Response in Haemodialysis patients: A prospective, multicenter, cohort studySemantic proximity
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patientsSemantic proximity
A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individualsSemantic proximity
Longitudinal SARS-CoV-2 neutralization of Omicron BA.1, BA.5 and BQ.1.1 after four vaccinations and the impact of break-through infections in hemodialysis patientsSemantic proximity
Improved SARS-CoV-2 neutralization of Delta and Omicron variants of concern after fourth vaccination in hemodialysis patientsSemantic proximity
Antibody and T-Cell Responses 6 Months after Covid-19 mRNA-1273 Vaccination in Patients with Chronic Kidney Disease, on Dialysis, or Living with a Kidney TransplantSemantic proximity
Select a neighboring publication to make it the new centre.